Benefit of Mineralocorticoid Receptor Antagonism in AKI: Role of Vascular Smooth Muscle Rac1-Reference-Cited by-同舟云学术

Benefit of Mineralocorticoid Receptor Antagonism in AKI: Role of Vascular Smooth Muscle Rac1

Published:2017-01-13 Issue:4 Volume:28 Page:1216-1226
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Barrera-Chimal Jonatan,André-Grégoire Gwennan,Nguyen dinh Cat Aurelie,Lechner Sebastian M.,Cau Jérôme,Prince Sonia,Kolkhof Peter,Loirand Gervaise,Sauzeau Vincent,Hauet Thierry,Jaisser Frédéric

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference38 articles.

1. Incidence and Outcomes in Acute Kidney Injury: A Comprehensive Population-Based Study

2. Chronic kidney disease following acute kidney injury—risk and outcomes

3. Renal Hemodynamics in AKI: In Search of New Treatment Targets

4. Pathophysiology of ischemic acute kidney injury

5. Cellular pathophysiology of ischemic acute kidney injury

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HACE1 exerts a neuroprotective role against oxidative stress in cerebral ischemia–reperfusion injury by activating the PI3K/AKT/Nrf2 pathway;Neuroscience;2024-11

2. The mineralocorticoid receptor in diabetic kidney disease;American Journal of Physiology-Renal Physiology;2024-09-01

3. Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease;Journal of the American Heart Association;2024-06-18

4. Nonsteroidal mineralocorticoid receptor blockers as a new tool for managing cardiorenal risks in type 2 diabetes mellitus;FOCUS. Endocrinology;2024-05-13

5. Krüppel-like factor 4 modulates the miR-101/COL10A1 axis to inhibit renal fibrosis after AKI by regulating epithelial–mesenchymal transition;Renal Failure;2024-02-12